Skip to main content

Advertisement

SpringerLink
Log in

Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Atherosclerotic cardiovascular complications represent significant cause of mortality in hemodialysis (HD) patients. The aims of this study were to: (a) investigate association of sICAM-1, sVCAM-1, omentin-1 and other non-traditional risk factors with subclinical atherosclerosis; (b) examine the diagnostic value of these specific markers in the early detection of subclinical atherosclerosis; and (c) examine their role as predictors of mortality in group of patients with subclinical atherosclerosis on regular HD.

Materials and methods

Starting from November 2011, a cohort of 210 HD patients participated in this 3-year follow-up study. The subjects were divided into three groups according to the presence of atherosclerosis. Atherosclerotic disease was assessed by measuring carotid intima-media thickness (IMT). Samplings were withdrawn at baseline and thereafter every 12 months until the end of follow-up.

Results

IMT showed weak correlation with sICAM-1 (r = 0.39, P = 0.001), sVCAM-1 (r = 0.27, P = 0.015) and omentin-1 (r = −0.25, P = 0.020), and also omentin-1 showed good correlation with parameters of systolic and diastolic function (r = 0.52, P = 0.001 and r = 0.51, P = 0.001). Multivariate analysis showed that sICAM-1 and sVCAM-1 concentrations were a strong independent correlate of IMT (P = 0.031 and P = 0.010, respectively). The Cox proportional analysis showed that sICAM-1 and omentin-1 concentrations were strong predictors of cardiovascular death (HR 1.85, CI 1.18–2.32, P = 0.021 and HR 4.14, CI 1.38–12.1, P = 0.004, respectively) and that serial measurements of these markers predict IMT progression (HR 1.98, 95 % CI 1.21–2.38, P < 0.002 and HR 2.91, 95 % CI 1.57–4.72, P < 0.001, respectively).

Conclusions

Our study demonstrated that sICAM-1 and omentin-1 levels are strong predictors of cardiovascular death in HD patients with subclinical atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tsimihodimos V, Dounousi E, Siamopoulos CK (2008) Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 28:958–973. doi:10.1159/000144024

    Article  CAS  PubMed  Google Scholar 

  2. Yao Q, Filiho PR, Lindholm B, Stenvinkel P (2004) Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end stage renal disease. Scand J Urol Nephrol 38:405–416. doi:10.1080/00365590410031715

    Article  PubMed  Google Scholar 

  3. Papagianni A, Kalovoulus M, Kirmizis D, Vainas A, Belechri AM, Alexopoulos E et al (2003) Carotid atherosclerosis is associated with inflammation and endothelia cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 18:113–119. doi:10.1093/ndt/18.1.113

    Article  CAS  PubMed  Google Scholar 

  4. Collado S, Coll E, Nicolau C, Pons M, Cruzado JM, Pascual J, Cases A (2015) Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study. PLoS ONE 10:e0127344. doi:10.1371/journal.pone.0127344

    Article  PubMed  PubMed Central  Google Scholar 

  5. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:27–32. doi:10.1161/01.CIR.0000131515.03336.f8

    Article  Google Scholar 

  6. Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J (2013) Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem 46:1353–1371. doi:10.1016/j.clinbiochem.2013.05.070

    Article  CAS  PubMed  Google Scholar 

  7. Kilic ID, Findikoglu G, Alihanoglu YI, Yildiz BS, Uslu S, Rota S et al (2014) Circulating adhesion molecules and arterial stiffness. Cardiovasc J Afr 26:21–24. doi:10.5830/CVJA-2014-060

    Article  Google Scholar 

  8. Gross MD, Bielinski SJ, Suarez-Lopez JR, Reiner AP, Baily K, Thyagarajan B et al (2012) Circulating soluble intracellular adhesion molecule 1 and subclinical atherosclerosis: the coronary artery risk development in young adults study. Clin Chem 58:411–420. doi:10.1373/clinchem.2011.168559

    Article  CAS  PubMed  Google Scholar 

  9. Güray U, Erbay AR, Güray Y, Yilmaz MB, Boyaci AA, Samaz H et al (2004) Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 96:235–240. doi:10.1016/j.ijcard.2003.07.014

    Article  PubMed  Google Scholar 

  10. Tan KB, Adya R, Randeva SH (2010) Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20:143–148. doi:10.1016/j.tcm.2010.12.002

    Article  CAS  PubMed  Google Scholar 

  11. Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fernandez-Real JM (2011) Circulating omentin as a novel marker of endothelial dysfunction. Obesity 19:1552–1559. doi:10.1038/oby.2010.351

    Article  CAS  PubMed  Google Scholar 

  12. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ et al (2011) Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 32:873–878. doi:10.1038/aps.2011.26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA et al (2001) Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 10:103–110. doi:10.1186/1475-2840-10-103

    Article  Google Scholar 

  14. Toth PP (2008) Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract 62:1246–1254. doi:10.1111/j.1742-1241.2008.01804.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Singh S, Nagra A, Maheshwari P, Panwar R, Hecht H, Fukumoto T et al (2013) Rapid screening for subclinical atherosclerosis by carotid ultrasound examination. Glob Heart 8:83–89. doi:10.1016/j.gheart.2013.05.001

    Article  PubMed  Google Scholar 

  16. Narumi T, Watanabe T, Kadowaki S, Kinoshita D, Yokoyama M, Honda Y et al (2014) Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc Diabetol 13:84–91. doi:10.1186/1475-2840-13-84

    Article  PubMed  PubMed Central  Google Scholar 

  17. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y et al (2011) Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219:811–814. doi:10.1016/j.atherosclerosis.2011.08.017

    Article  CAS  PubMed  Google Scholar 

  18. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B et al (2001) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13:S28–S36

    Google Scholar 

  19. Tripepi G, Raso FM, Sijbrands E, Seck MS, Maas R, Boger R et al (2001) Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol 6:1714–1721. doi:10.2215/CJN.11291210

    Article  Google Scholar 

  20. Bazeley JK, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C et al (2001) C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 6:2452–2461. doi:10.2215/CJN.00710111

    Article  Google Scholar 

  21. Kanda E, Bieber BA, Pisoni RL, Robinson BM, Fuller DS (2015) Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients’ mortality and development of a novel index: dialysis outcomes and practice patterns study. PLoS ONE 10:e0128652. doi:10.1371/journal.pone.0128652

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kwan BCH, Kronenberg F, Beddhu S, Cheung AK (2007) Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 18:1246–1261. doi:10.1681/ASN.2006091006

    Article  CAS  PubMed  Google Scholar 

  23. Mallamaci F, Zoccali C, Tripei G, Fermo I, Benedetto FA, Cataliotti A et al (2002) Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609–614. doi:10.1046/j.1523-1755.2002.00144.x

    Article  PubMed  Google Scholar 

  24. Ulusoy S, Özkan G (2013) Lipid abnormalities in hemodialysis patients. In: Suzuki H (ed) Hemodialysis. http://www.intechopen.com/books/hemodialysis/lipid-abnormalities-in-hemodialysis-patients

  25. Chang JF, Hsu SP, Pai MF, Yang JY, Wu HY et al (2013) High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients. Int Urol Nephrol 45:1693–1701. doi:10.1007/s11255-013-0425-z

    Article  CAS  PubMed  Google Scholar 

  26. Alcelik A, Tosun M, Ozlu MF, Eroglu M, Aktas G, Kemahli E et al (2012) Serum levels of omentin in end stage renal disease patients. Kidney Blood Press Res 35:511–516. doi:10.1159/000338796

    Article  CAS  PubMed  Google Scholar 

  27. Tawfeeka HM, Maghrapyb HM, Elsaidb FM, Eliazeedc HA (2014) Relationship between omentin-1 and carotid intima thickness in type 2 diabetes mellitus Egypt. J Intern Med 26:68–74. doi:10.4103/1110-7782.139547

    Google Scholar 

  28. Shibata R, Takahashi R, Kataoka Y, Ohashi K, Ikeda N, Kihara S et al (2011) Association of fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res 34:1309–1312. doi:10.1038/hr.2011.130

    Article  CAS  PubMed  Google Scholar 

  29. Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y (2010) Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 393:668–672. doi:10.1016/j.bbrc.2010.02.053

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

In this study, the reagents kit for adhesion molecules were provided free of charge by H.K.O. medical systems, Zagreb, and MEDiLAB, Zagreb. Reagents for homocysteine were provided free of charge by Abbott laboratories, Zagreb, and reagents for Lp (a) were provided free of charge by Beckman Coulter, Zagreb.

Author information

Authors and Affiliations

  1. Department of Laboratory Diagnostics, Primary Health Care of Primorsko-Goranska County, Kresimirova 52, 51000, Rijeka, Croatia

    Marija Kocijancic

  2. Department of Cardiovascular Disease, Clinical Hospital Centre Rijeka, Rijeka, Croatia

    Zlatko Cubranic & Luka Zaputovic

  3. Department of Nephrology and Dialysis, Clinical Hospital Centre Rijeka, Rijeka, Croatia

    Bozidar Vujicic & Sanjin Racki

  4. Clinical Department of Laboratory Medicine, Clinical Hospital Centre Rijeka, Rijeka, Croatia

    Stefica Dvornik

Authors
  1. Marija Kocijancic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zlatko Cubranic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bozidar Vujicic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sanjin Racki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefica Dvornik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luka Zaputovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marija Kocijancic.

Ethics declarations

Conflict of interest

Authors wish to confirm that there are no known conflicts of interest associated with this publication. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kocijancic, M., Cubranic, Z., Vujicic, B. et al. Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients. Int Urol Nephrol 48, 1145–1154 (2016). https://doi.org/10.1007/s11255-016-1275-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-016-1275-2

Keywords

Search

Navigation